Condition
Recurrent Adenoid Cystic Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Adenoid Cystic Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (2), France (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Treatment of advanced Adenoid Cystic Carcinoma with REM-422
This study is testing a new oral medication called REM-422 to see if it can safely shrink tumors in people with advanced Adenoid Cystic Carcinoma that keeps coming back or has spread.
-
CB-103 combined with lenvatinib or abemaciclib for NOTCH-activated adenoid cystic carcinoma
This study tests whether combining the NOTCH inhibitor CB-103 with either lenvatinib or abemaciclib can slow tumor growth in adults with NOTCH-activated advanced or metastatic adenoid cystic carcinoma.
Related topics
Quick answers
How many Recurrent Adenoid Cystic Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.